Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

1. Resveratrol provides benefits in mice with type II diabetes-induced chronic renal failure through AMPK signaling pathway.Experimental and therapeutic medicine · 2018
   Article
2. Plasma Metanephrines Are Associated With Glucose Metabolism in Patients With Essential Hypertension.Medicine · 2015
   Observational
3. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.BMC medical genomics · 2009
   Article
4. The ADVANCE trial: further PROGRESS with HOPE.Journal of human hypertension · 2007
   Article
5. The 2007 revised ESC/ESH Guidelines in the management of hypertension: clarifying individual patient care.Journal of human hypertension · 2007
   Article
6. Five-year incidence of hypertension and its determinants: the ATTICA study.Journal of human hypertension · 2007
   Article
7. New insights into complement C3 and inflammation in hypertension.Journal of human hypertension · 2007
   Article
8. Towards understanding the aetiology and pathophysiology of human hypertension: where are we now?Journal of human hypertension · 2006
   Article
9. Insights into human hypertension: the role of endothelial dysfunction.Journal of human hypertension · 2006
   Article
10. Blood pressure control in the setting of diabetes mellitus: new targets, new hope for improvement?Journal of human hypertension · 2006
    Article
11. Do increased plasma adrenomedullin levels in normotensive subjects precede hypertension?Journal of human hypertension · 2006
    Article
12. Statins and hypertension.Journal of human hypertension · 2006
    Article

Corrections and comments

• Comment on
  Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial.2005

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as